Departments

Departments

Back


Dermatology Director：AKIYAMA, Masashi (Professor)

All skin problems are within our field

All the symptoms and changes on the skin fall within the domain of dermatologists. Even if such symptoms or changes are the result of systemic diseases, our department will treat them as long as they are on the skin


Medical Care System

General outpatient clinic: Monday through Friday
Skin tumor outpatient clinic: Monday afternoon, Tuesday, Wednesday, and Friday Collagen disorder outpatient clinic: Monday and Thursday
Outpatient clinic for ichthyosis and inherited dyskeratosis: Wednesday
Inflammatory keratosis and generalized pustular psoriasis outpatient clinic: Tuesday
(All these indications are for the first visit.)

Target Diseases

Skin cancers (e.g., malignant melanoma, squamous cell carcinoma, extramammary Paget's disease, angiosarcoma), collagen disorders (e.g., lupus erythematosus, dermatomyositis, scleroderma, Sjogren's syndrome), genetic skin diseases (e.g., dyskeratosis, ichthyosis, epidermolysis bullosa), inflammatory keratosis (e.g., generalized pustular psoriasis), atopic dermatitis, urticaria, and other skin diseases.

Strong Fields

Diagnosis and treatment of skin cancers (systemic and multidisciplinary treatments including chemotherapy and immune checkpoint inhibitors, clinical trials, personalized medicine using cancer multi-gene panel testing, and advanced medical care), diagnosis and treatment of collagen disorders, genetic testing of a variety of genetic skin diseases, and detection of pathogenic factors of atopic dermatitis (filaggrin gene mutations), pustular psoriasis (IL36RN gene mutation).

Clinical Results

We operate on 350 skin tumor cases per year. More than 30 patients are currently undergoing chemotherapy treatment on an outpatient basis. Cancer multi-gene panel testing has been performed on more than 20 cases so far. The cumulative number of cases that have undergone sentinel lymph node biopsy is 200. Currently, the department has more than 200 outpatients affected with collagen disorders, such as lupus erythematosus, dermatomyositis and scleroderma. The cumulative number of genetic tests conducted on patients with intractable genetic skin diseases is 300.

Specialized Outpatient Clinic

Skin tumor, collagen disorder, ichthyosis and inherited dyskeratosis, inflammatory keratosis and generalized pustular psoriasis, and general dermatology

Advanced Medicine and Research

Advanced medical treatment using cancer multi-gene panel testing for skin cancers, and multi-center clinical trials; tailor-made care of atopic dermatitis by detection of filaggrin gene mutations; research on the roles of various autoantibodies in the onset of collagen disorders; development of assay kits for diagnostic autoantibodies; and genetic testing and prenatal diagnosis for intractable genetic skin diseases, such as ichthyosis, inflammatory keratosis and generalized pustular psoriasis, epidermolysis bullosa.